ALKBH5 knockdown promotes glucose uptake in TC xenografts through activation of circNRIP1-mediated glycolytic functions of tumor cells by sponging oncogenic miR-541-5p and miR-3064-5p as well as by upregulating pyruvate kinase M2 (PKM2) levels [67]. This evidence concerns the gene ALKBH5 and neoplasm.